Advantages and clinical applications of natural killer cells in cancer immunotherapy-Reference-Cited by-同舟云学术

Advantages and clinical applications of natural killer cells in cancer immunotherapy

Published:2013-08-30 Issue:1 Volume:63 Page:21-28
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Ames Erik,Murphy William J.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-013-1469-8.pdf

Reference52 articles.

1. Hallett WH, Murphy WJ (2006) Positive and negative regulation of natural killer cells: therapeutic implications. Semin Cancer Biol 16:367–382. doi: 10.1016/j.semcancer.2006.07.003

2. Bennett M (1987) Biology and genetics of hybrid resistance. Adv Immunol 41:333–445

3. Bennett M (1973) Prevention of marrow allograft rejection with radioactive strontium: evidence for marrow-dependent effector cells. J Immunol 110:510–516

4. Herberman RB, Nunn ME, Lavrin DH (1975) Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 16:216–229

5. Kiessling R, Klein E, Wigzell H (1975) “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 5:112–117. doi: 10.1002/eji.1830050208

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of stress-attributed breast cancer incidence and progression;Cancer Causes & Control;2024-07-16

2. Evolution of natural killer cell-targeted therapy for acute myeloid leukemia;International Journal of Hematology;2024-05-01

3. Tumor microenvironment and immune system preservation in early-stage breast cancer: routes for early recurrence after mastectomy and treatment for lobular and ductal forms of disease;BMC Immunology;2024-01-25

4. Tumor microenvironment and immune system preservation in early-stage breast cancer: Routes for early recurrence after mastectomy and treatment for lobular and ductal forms of disease;2023-10-10

5. Update on immune‐based therapy strategies targeting cancer stem cells;Cancer Medicine;2023-09